Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: HiberGene Dx Names New CEO; BioFire Dx Appoints CFO

Premium

Infectious disease diagnostics developer HiberGene Diagnostics has appointed Tony Hill as CEO.

Hill joins HiberGene from Innogenetics, where he was global sales director. Prior to this, he was vice president at OraSure Technologies, and he has also held a number of positions at Sigma Aldrich.

HiberGene has developed a molecular diagnostic test for Meningococcus and plans to develop a test for pneumococcal meningitis, the two most common forms of meningitis. Using a novel rapid amplification platform, HiberGene has produced a rapid and highly sensitive diagnostic test that can be used in almost any clinical or laboratory setting, the company said. HiberGene is currently fundraising to help commercialize the assays and fund further ongoing research and development on a range of infectious diseases.


BioFire Diagnostics has appointed Robert Lollini as CFO.

Lollini most recently served as CEO, and formerly as CFO of Myrexis, a Utah-based biotechnology company. He remains a member of its board of directors. From 1993 to 2007, Lollini held multiple executive positions at drug-delivery company Iomed, which was acquired in May 2007. Earlier in his career, he held various executive management positions at RP Scherer.

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.